Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Susan C Orr"'
Publikováno v:
Patient-Centered Digital Healthcare Technology: Novel applications for next generation healthcare systems ISBN: 9781785615658
Patient-Centered Digital Healthcare Technology: Novel applications for next generation healthcare systems
Patient-Centered Digital Healthcare Technology: Novel applications for next generation healthcare systems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c361fcb60faa49eea65f7133cfd8fa9
https://doi.org/10.1049/pbhe017e_ch4
https://doi.org/10.1049/pbhe017e_ch4
Autor:
Allen C. Ho, Eleanor L Smith, Jeffrey S. Heier, Richard L. Lindstrom, Grace C Chang, Flora Lum, John S. Pollack, David M. Kleinman, Susan C Orr
Publikováno v:
Ophthalmic surgery, lasersimaging retina. 51(11)
BACKGROUND AND OBJECTIVE: Clinical trials in neovascular age-related macular degeneration (nAMD) demonstrate that high visual acuity (VA) can be maintained, and low VA can be improved with anti-vascular endothelial growth factor (VEGF) treatment. Few
Autor:
Bette A McCue, Kenneth N Sall, Susan C Orr, Harold R. Katz, R. Faulkner, D.C. Dahlin, Samuel Masket, Stephen S. Lane
Publikováno v:
Cornea. 24:955-958
Purpose To investigate the absorption of moxifloxacin into human aqueous humor after administration of moxifloxacin hydrochloride ophthalmic solution, 0.5% as base. Methods Cataract patients were randomly allocated to receive 1 drop every 15 minutes
Autor:
Renee Pierson, Jennifer Bogert, Ross D. Crosby, Susan C Orr, Terri Malone, Susan D. Mathias, Tom S. Chang
Publikováno v:
Value in Health. 19:A127
Autor:
Marlene R. Moster, Cynthia Pailliotet, Kenneth N Sall, Najam A. Sharif, M. Curtis, Kimberly Martens, R. Faulkner, E. Randy Craven, D.C. Dahlin, Jess T. Whitson, Harvey Dubiner, Susan C Orr
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 26(2)
To quantify the aqueous humor (AH) concentrations of bimatoprost (amide), travoprost (isopropyl ester), and their hydrolysis products, bimatoprost free acid (BFA) and travoprost free acid (TFA), after multiple topical ocular doses of LUMIGAN and TRAV